Enhancing clinical trial safety
By Altasciences Clinical Research
Altasciences Clinical Research’s chief R&D officer, Dr Graham Wood, explains how the integration of adaptive trial designs and dual-purpose biomarkers of efficacy enhance safety in early-phase clinical trials.